AC Immune (ACIU)
(Delayed Data from NSDQ)
$2.36 USD
-0.02 (-0.84%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $2.36 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 4/26/24 |
---|---|
Current Quarter | -0.12 |
EPS Last Quarter | -0.06 |
Last EPS Surprise | 14.29% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.78 |
Next Year | -0.27 |
EPS (TTM) | -0.71 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.14M | 1.14M | 14.15M | 69.17M |
# of Estimates | 1 | 1 | 2 | 3 |
High Estimate | 1.14M | 1.14M | 16.95M | 150.76M |
Low Estimate | 1.14M | 1.14M | 11.35M | 27.69M |
Year ago Sales | 0.00M | 0.00M | 16.71M | 14.15M |
Year over Year Growth Est. | NA | NA | -15.30% | 388.83% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.12 | -0.22 | -0.78 | -0.27 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -0.04 | -0.23 | -0.71 | 0.41 |
High Estimate | -0.04 | -0.20 | -0.71 | 0.41 |
Low Estimate | -0.19 | -0.23 | -0.88 | -0.66 |
Year ago EPS | -0.23 | -0.22 | -0.71 | -0.78 |
Year over Year Growth Est. | 47.83% | 0.00% | -9.86% | 64.53% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.12 | -0.22 | -0.78 | -0.27 |
7 Days Ago | -0.12 | -0.22 | -0.78 | -0.27 |
30 Days Ago | -0.12 | -0.22 | -0.78 | -0.27 |
60 Days Ago | NA | NA | -0.54 | -0.29 |
90 Days Ago | NA | NA | -0.54 | -0.29 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.12 | -0.22 | -0.78 | -0.27 |
Zacks Consensus Estimate | -0.12 | -0.22 | -0.78 | -0.27 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.06 | -0.20 | -0.22 | -0.23 | NA |
Estimate | -0.07 | 0.00 | -0.22 | -0.24 | NA |
Difference | 0.01 | -0.20 | 0.00 | 0.01 | -0.05 |
Surprise | 14.29% | NA | 0.00% | 4.17% | 6.15% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more